The Program comprises a number of interactive and overlapping focus groups, which have continued to be productive, and form the basis for a high degree of interaction and collaboration. The Viral Oncogenesis focus group has a strong emphasis on the role of viruses as mediators of human cancers, including studies of Epstein-Barr virus (EBV), Kaposi's Sarcoma Herpesvirus (KSHV), human cytomegalovirus (HCMV), human papilloma virus (HPV) and hepatitis C virus (HCV), as well as other known tumor viruses: SV40 and Adenovirus. The DNA Virology focus group includes an excellent group of herpesvirus investigators who are studying herpes simplex viruses 1 and 2 and are focusing their work on viral infection and establishment of latency. The Retrovirology focus group studies HIV and AIDS-related malignancies as well as oncogenic murine retroviruses. The Viral Receptor focus group has strengths related to viral receptors and virus receptor interactions. The group includes members who have made major advances in understanding HIV receptors, avian leukosis virus (ALV) receptors and herpes simplex receptors. The General Virology focus group includes investigators studying Arbo-viruses, Corona-viruses and Bunya-viruses. Although not directly related to cancer, these investigators bring to the program expertise in RNA virology and classical virology, which have provided depth to the program and have proven vital for the general understanding of virus-host interactions. The general areas of viral-related research in the Tumor Virology Program include: 1) studies to determine the mechanisms mediating cellular transformation, immortalization and cell cycle dysregulation by viral encoded proteins;2) studies to understand the role of viral proteins on cellular and viral gene expression and on control of cell metabolism, growth and survival;3) research involving the structure and function of viral receptors and viral-receptor interactions;4) investigation of the molecular biology and pathogenesis of retroviruses as they relate to AIDS and AIDS-associated malignancies;5) studies focused on elucidation of the mechanisms of viral neuropathology;6) studies to develop viral vectors for human gene therapy and cancer;and 7) development of vaccine strategies for the treatment of viral-associated cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-38
Application #
8593248
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$97,336
Indirect Cost
$86,402
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lang, Fengchao; Sun, Zhiguo; Pei, Yonggang et al. (2018) Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog 14:e1007253
Rosenfeld, Aaron M; Meng, Wenzhao; Luning Prak, Eline T et al. (2018) ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data. Front Immunol 9:2107
Kushner, Carolyn J; Hwang, Wei-Ting; Wang, Shiyu et al. (2018) Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer. Breast Cancer Res Treat 170:45-53
Buljan, Vlado A; Graeber, Manuel B; Holsinger, R M Damian et al. (2018) Calcium-axonemal microtubuli interactions underlie mechanism(s) of primary cilia morphological changes. J Biol Phys 44:53-80
Min, Eun Jeong; Safo, Sandra E; Long, Qi (2018) Penalized Co-Inertia Analysis with Applications to -Omics Data. Bioinformatics :
Chang, Changgee; Kundu, Suprateek; Long, Qi (2018) Scalable Bayesian variable selection for structured high-dimensional data. Biometrics :
Pei, Yonggang; Singh, Rajnish Kumar; Shukla, Sanket Kumar et al. (2018) Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2. J Virol 92:
Singh, Rajnish Kumar; Lang, Fengchao; Pei, Yonggang et al. (2018) Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia. PLoS Pathog 14:e1007062
Micallef, Ivana N; Stiff, Patrick J; Nademanee, Auayporn P et al. (2018) Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. Biol Blood Marrow Transplant 24:1187-1195
Nicastri, Michael C; Rebecca, Vito W; Amaravadi, Ravi K et al. (2018) Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells. Mol Cell Oncol 5:e1395504

Showing the most recent 10 out of 1047 publications